← Return to Evenity safer than Tymlos / Forteo for Cardio Vascular Risk?

Discussion

Evenity safer than Tymlos / Forteo for Cardio Vascular Risk?

Osteoporosis & Bone Health | Last Active: May 16 10:04pm | Replies (11)
Comment receiving replies
@michaellavacot

Good point, could be. I only have the abstract to go by right now but it does state "matched cohorts were created 1:1 using demographic variables, comorbidities, and medications". Not much to go by. Maybe someone will pay the $41 to get the full study 🙂

Jump to this post

Replies to "Good point, could be. I only have the abstract to go by right now but it..."
njhornung | @normahorn | Apr 14 11:17am

I have learned to look at exclusion criteria for trials. I was rejected because of my bone marrow disorder for one that was evaluating the use of EQUOL for addressing arterial stiffness. Recently there was a post about one looking at alternating Evenity with ReClast. That one listed having a bone marrow disorder as an exclusion.

VIEW AND REPLY